
| This scientist hopes to test coronavirus drugs on animals in locked-down Wuhan #MMPMID31992886Cyranoski DNature 2020[Jan]; 577 (7792): 607 PMID31992886show ga
?|*Drug Evaluation, Preclinical[MESH]|Angiotensin-Converting Enzyme 2[MESH]|Animals[MESH]|Antiviral Agents/*pharmacology/supply & distribution/therapeutic use[MESH]|COVID-19[MESH]|COVID-19 Drug Treatment[MESH]|China/epidemiology[MESH]|Clinical Trials as Topic[MESH]|Coronavirus Infections/*drug therapy/epidemiology/veterinary/virology[MESH]|Coronavirus/*drug effects[MESH]|Disease Models, Animal[MESH]|Humans[MESH]|Mice[MESH]|Middle East Respiratory Syndrome Coronavirus/drug effects[MESH]|Patient Selection[MESH]|Peptidyl-Dipeptidase A/genetics/metabolism[MESH]|Pneumonia, Viral/*drug therapy/epidemiology/veterinary/*virology[MESH]|Severe Acute Respiratory Syndrome/*drug therapy/virology[MESH]|Severe acute respiratory syndrome-related coronavirus/drug effects[MESH]
  
DeepDyve Pubget Overpricing | 
|